Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg.

导出 OA

翻译打印收藏纠错

作者： Klervi,Golhen ^[1] ; Michael,Buettcher ^[2] ; Jörg,Huwyler ^[3] ; John,van den Anker ^[4] ; Verena,Gotta ^[1] ; Kim,Dao ^[5] ; Laura E,Rothuizen ^[5] ; Kevin,Kobylinski ^[6] ; Marc,Pfister ^[1]

作者单位： Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, 4056 Basel, Switzerland. ^[1] Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, 4056 Basel, Switzerland.;Pediatric Infectious Diseases, Children's Hospital of Central Switzerland (KidZ), Lucerne Cantonal Hospital, 6000 Luzern, Switzerland.;Faculty of Health Sciences and Medicine, University of Lucerne, 6000 Luzern, Switzerland. ^[2] Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland. ^[3] Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, 4056 Basel, Switzerland.;Division of Clinical Pharmacology, Children's National Hospital, Washington, DC 20001, USA. ^[4] Clinical Pharmacology Service, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland. ^[5] Mahidol Oxford Tropical Medicine Research Unit (MORU), Bangkok 10400, Thailand. ^[6]

关键词 STROMECTOL?TIP-based technology absorption dosing ivermectin novel delivery systems oral drug delivery orodispersible tablet (ODT)pharmacometrics variability

DOI 10.3390/pharmaceutics16091186

PMID 39339222

发布时间 2024-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交